跳至主要内容
临床试验/JPRN-UMIN000016670
JPRN-UMIN000016670已完成未知

Phase I/II study of intravenous and intraperitoneal paclitaxel for peritoneal metastasis after resection of pancreatic cancer refractory to gemcitabine and fluoropyrimidine chemotherapy - Intravenous and intraperitoneal paclitaxel for peritoneal metastasis after resection of pancreatic cancer

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine0 个研究点目标入组 35 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Metastasis to other distant organsuch as the liver, lungs or bone; other active concomitant malignancies; other severe medical conditions; contraindication of Paclitaxel, Pregnant woman, no informed consent

研究者

发起方
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine

相似试验